Papatheodoridi M. Rates and predictors of HBsAg loss after discontinuation of effective long-term Entecavir or Tenofovir therapy in non-cirrhotic HBeAg-negative Chronic Hepatitis B patients: Results from the DARING-B prospective Greek study. PS-159.
“Wisselen naar generiek is mogelijk, de kern blijft de hiv-patiënt goed te informeren”
sep 2018 | HIV